Another potential treatment which has shown signs of possible positive effect, remdesivir, was also cited by trump as being very “near” approval for use by the FDA. Hahn clarified that in fact, while remdesivir is currently undergoing clinical trials, it’s following the normal FDA process for approval for clinical medical therapeutic use in the U.S. He did say he was declined to comment on ongoing commercial arrangements with remdesivir maker Gilead when asked when we might expect the drug to be available commercially.
Hahn also highlighted another experimental treatment possibility that the FDA is investing: Using plasma derived from blood taken from coronavirus patients who have recovered, and injecting that into other patients in an attempt to potentially jump start their own immune response.
FDA testing coronavirus treatments, including chloroquine, plasma from recovered COVID-19 patients – TechCrunch
Hahn also highlighted another experimental treatment possibility that the FDA is investing: Using plasma derived from blood taken from coronavirus patients who have recovered, and injecting that into other patients in an attempt to potentially jump start their own immune response.
FDA testing coronavirus treatments, including chloroquine, plasma from recovered COVID-19 patients – TechCrunch